Mounjaro®
Starting from £179.99/mo
Start journey Learn moreOvereating on Mounjaro typically causes intense nausea, vomiting, stomach pain and bloating. Tirzepatide slows the rate at which the stomach empties, so eating past fullness means food sits longer than usual — and your body will let you know. The discomfort tends to pass within a few hours, but it can be significant. These are prescription-only medicines; a prescriber assesses whether treatment is right for you before any is dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
To understand why overeating on Mounjaro hits so hard, it helps to start with the mechanism. Tirzepatide activates both GIP and GLP-1 receptors, the only licensed weight-loss medicine in the UK to work on both pathways simultaneously. One of the practical results is a significant reduction in gastric emptying speed: food moves from your stomach into the small intestine more slowly than it would without treatment. This is partly why appetite falls and meals feel satisfying sooner.
On a normal eating day, this works in your favour. You feel full earlier, you eat less, and comfort lingers. The Mounjaro overview covers this mechanism in more detail. But that slowed transit has a flip side: your stomach's buffer space is effectively reduced. Once you've hit genuine fullness, there is less margin to keep eating without consequence than there would be off treatment.
The discomfort that follows overeating isn't a side effect in the traditional sense, it's the medicine doing exactly what it's designed to do, amplified by eating beyond the point of satiety. Most people find the signal arrives quickly and unmistakably. That's actually useful information once you learn to read it.
The first thing most people notice is bloating and a sensation of uncomfortable fullness that doesn't ease the way it might have before treatment. Nausea usually follows within minutes to an hour, and it can escalate to vomiting if a significant amount was eaten. Acid reflux and burping are common; the backed-up gastric contents have nowhere comfortable to go.
How severe the symptoms are depends on several factors: where you are in your titration schedule, how much you ate, the fat and fibre content of the meal (high-fat food slows emptying further), and how quickly you ate. Early in a new dose increase, the stomach-slowing effect is at its most pronounced, so a meal that caused mild discomfort at 2.5mg may produce a much stronger reaction at 7.5mg or 10mg.
For most people, the peak is within the first couple of hours. A quiet position, small sips of plain water, and waiting it out is the standard approach. If vomiting is severe or prolonged, or if you become dehydrated and cannot keep fluids down, that warrants a call to your prescriber or NHS 111, dehydration is the complication worth watching. The separate question of overdose is worth distinguishing: accidentally eating too much food is different from taking more medication than prescribed, and the clinical responses differ accordingly.
The short-term discomfort is unpleasant. The longer-term picture is arguably more important for people who are trying to get the most from their treatment. Tirzepatide's weight-management benefits depend, in part, on consistent calorie reduction. Repeated overeating (even if it ends in nausea) can slow or stall progress. The medicine reduces appetite substantially for most people, so frequent overeating often signals something else worth unpacking: social eating pressure, habitual patterns that run on autopilot, emotional eating, or a specific type of food that is easy to overconsume even when the stomach signals fullness.
High-fat, high-sugar foods and ultra-processed snacks are particularly likely to cause problems. They are energy-dense, often eaten quickly before satiety kicks in, and slow gastric emptying further. Protein and vegetables, eaten slowly, tend to be more forgiving. Our clinical team at nume's clinical oversight page outlines how the prescribing process takes your diet history into account from the start, but day-to-day guidance is best given by a dietitian working alongside your prescriber.
It's also worth noting that not eating enough on Mounjaro carries its own risks, particularly around muscle loss and nutrient gaps. The goal isn't to restrict aggressively, it's to respond to the body's recalibrated hunger signals. Smaller portions, eaten deliberately, tend to be the pattern that works best over time. Understanding what happens after Mounjaro treatment helps contextualise why building those habits now matters for the long term.
After an overeating episode, the practical priorities are rest and hydration. Lying flat can worsen reflux; sitting upright or propped up is more comfortable. Small amounts of plain water are easier to tolerate than any food. Most people feel substantially better within two to four hours, though some residual bloating can last longer.
There's no need to skip the next dose because you overate, the injection schedule continues as normal. Missing doses disrupts the stable plasma level tirzepatide needs to work effectively. What is worth doing is mentioning the episode to your prescriber at your next review, particularly if it happens regularly. They can assess whether your titration pace is right, whether a particular meal type is consistently triggering problems, and whether any additional support is useful.
A practical note on your pen: keeping it stored properly in the fridge door (2–8°C) means it's there reliably every injection day, and the injection itself is unaffected by what you ate earlier in the week. If you have questions about how long the pen can be kept outside the fridge, the SmPC has the exact window, always the definitive source over any general guidance. Good storage habits and consistent dosing are the foundations; everything else, including navigating meals, builds on top of them.
If you haven't yet started treatment and are thinking about how tirzepatide might fit your daily life, you can start a free consultation with our prescribers, a real clinician reviews your answers the same day, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.